Experimental Urethral Infection with Neisseria gonorrhoeae.

Abstract

Gonorrhea rates and antibiotic resistance are both increasing. Neisseria gonorrhoeae (Ng) is an exclusively human pathogen and is exquisitely adapted to its natural host. Ng can subvert immune responses and undergoes frequent antigenic variation, resulting in limited immunity and protection from reinfection. Previous gonococcal vaccine efforts have been largely unsuccessful, and the last vaccine to be tested in humans was more than 35 years ago. Advancing technologies and the threat of untreatable gonorrhea have fueled renewed pursuit of a vaccine as a long-term sustainable solution for gonorrhea control. Despite the development of a female mouse model of genital gonococcal infection two decades ago, correlates of immunity or protection remain largely unknown, making the gonococcus a challenging vaccine target. The controlled human urethral infection model of gonorrhea (Ng CHIM) has been used to study gonococcal pathogenesis and the basis of anti-gonococcal immunity. Over 200 participants have been inoculated without serious adverse events. The Ng CHIM replicates the early natural course of urethral infection. We are now at an inflexion point to pivot the use of the model for vaccine testing to address the urgency of improved gonorrhea control. Herein we discuss the need for gonorrhea vaccines, and the advantages and limitations of the Ng CHIM in accelerating the development of gonorrhea vaccines.

• Authors: Andreea Waltmann, Joseph A Duncan, Gerald B Pier, Colette Cywes-Bentley, Myron S Cohen, Marcia M Hobbs
• Journal: Current topics in microbiology and immunology (Curr Top Microbiol Immunol) (Mar 05 2022) ISSN: 0070-217X [Print] Germany
• PMID: 35246736 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.